Frazier Life Sciences IX L.P. 13D and 13G filings for Passage Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-06-15 10:25 am Sale |
2023-06-13 | 13D | Passage Bio, Inc. PASG |
Frazier Life Sciences IX L.P. | 2,543,698 4.700% |
-1,213,217![]() (-32.29%) |
Filing |
2022-08-15 11:29 am Sale |
2022-08-11 | 13D | Passage Bio, Inc. PASG |
Frazier Life Sciences IX L.P. | 3,756,915 6.900% |
-1,264,523![]() (-25.18%) |
Filing |
2021-01-27 2:56 pm Purchase |
2021-01-26 | 13D | Passage Bio, Inc. PASG |
Frazier Life Sciences IX L.P. | 5,021,438 9.500% |
12,219![]() (+0.24%) |
Filing |